Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-01

Clinical Trial Update: Safety and Immunogenicity Study of the DuoChol Oral Cholera Vaccine in Healthy Participants [Phase 1]

View source ↗

Summary

This document notes a Phase 1 safety and immunogenicity study of the DuoChol Oral Cholera Vaccine in healthy participants, with status not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DuoChol Oral Cholera Vaccine

Snippet

Sponsor: International Vaccine Institute | Conditions: Cholera Vaccination Reaction | Phase 1 | Status: NOT_YET_RECRUITING